Literature DB >> 29909470

Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis.

P Szafors1, H Che1, T Barnetche2, J Morel1, C Gaujoux-Viala3, B Combe1, C Lukas4.   

Abstract

Inflammatory bowel diseases (IBDs) are associated with a decreased bone mineral density, but the impact on fractures is unknown. In our study, global risk of fracture is increased for patients with IBDs versus controls. This result will help to determine the appropriate assessment with early screening and management of osteoporosis. Inflammatory bowel diseases (IBDs), such as Crohn's disease (CD) and ulcerative colitis (UC), are associated with a decreased bone mineral density (BMD). However, the impact on fracture risk is unknown and data are contradictory across studies. In this systematic review and meta-analysis, we aimed to assess the risk of fracture and presence of low BMD in patients with IBDs compared to healthy controls. A systematic search of literature was conducted of MEDLINE, EMBASE, the Cochrane library and abstracts from appropriate scientific congresses. Studies were selected if they compared the incidence of fractures and/or BMD measurement by dual-energy X-ray absorptiometry in patients with IBDs and healthy sex- and age-matched controls. Data were extracted by two independent investigators. Meta-analysis was performed with the inverse variance approach to estimate pooled odds ratios (ORs) and risk ratios (RRs) with their 95% confidence intervals (CIs). Twenty-four studies met the inclusion criteria. On the basis of nine studies, global risk of fracture was increased for patients with IBDs versus controls (RR = 1.38, 95% CI 1.11-1.73; p = 0.005). Fracture risk with IBDs was significantly increased for vertebral fractures (OR = 2.26, 95% CI 1.04-4.90; p < 0.001), but not for any other site. The analysis of 16 studies evaluating BMD showed a significant decrease in mean BMD and Z-scores for IBD patients versus controls at all sites. In our meta-analysis, patients with IBDs have an increased risk of fractures, especially in the spine, and significant decreased BMD at all sites, which suggests the need for identifying high-risk individuals among this population.

Entities:  

Keywords:  Bone density; Fracture risk; Inflammatory bowel disease; Meta-analysis; Osteoporosis

Mesh:

Year:  2018        PMID: 29909470     DOI: 10.1007/s00198-018-4586-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  3 in total

1.  Calcaneal ultrasound bone densitometry in inflammatory bowel disease--a comparison with double x-ray densitometry of the lumbar spine.

Authors:  W Fries; M Dinca; G Luisetto; F Peccolo; F Bottega; A Martin
Journal:  Am J Gastroenterol       Date:  1998-12       Impact factor: 10.864

Review 2.  Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.

Authors:  P Vestergaard
Journal:  Minerva Med       Date:  2004-12       Impact factor: 4.806

3.  Evaluation of bone mineral density among patients with inflammatory bowel disease in a tertiary care setting in India.

Authors:  Rajesh Khadgawat; Govind K Makharia; Kanika Puri
Journal:  Indian J Gastroenterol       Date:  2008 May-Jun
  3 in total
  24 in total

Review 1.  The Regulation of Marrow Fat by Vitamin D: Molecular Mechanisms and Clinical Implications.

Authors:  Hanel Sadie-Van Gijsen
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

Review 2.  Human Relevance of Preclinical Studies on the Skeletal Impact of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Authors:  Swati Rajput; Poonam Mehta; Monika Mittal; Singh Rajender; Naibedya Chattopadhyay
Journal:  Calcif Tissue Int       Date:  2021-02-09       Impact factor: 4.333

3.  Overweight and abdominal fat are associated with normal bone mineral density in patients with ulcerative colitis.

Authors:  Mirella Brasil Lopes; Andre Castro Lyra; Raquel Rocha; Fernanda Gomes Coqueiro; Carla Andrade Lima; Carolina Cunha de Oliveira; Genoile Oliveira Santana
Journal:  World J Gastrointest Pharmacol Ther       Date:  2022-07-05

4.  Musculoskeletal Clinical and Imaging Manifestations in Inflammatory Bowel Diseases.

Authors:  Mihaela Ionela Sarbu; Nicolae Sarbu
Journal:  Open Med (Wars)       Date:  2019-02-20

5.  ESR1 Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn's Disease.

Authors:  Iwona Krela-Kaźmierczak; Marzena Skrzypczak-Zielińska; Marta Kaczmarek-Ryś; Michał Michalak; Aleksandra Szymczak-Tomczak; Szymon T Hryhorowicz; Marlena Szalata; Liliana Łykowska-Szuber; Piotr Eder; Kamila Stawczyk-Eder; Maciej Tomczak; Ryszard Słomski; Agnieszka Dobrowolska
Journal:  J Clin Med       Date:  2019-08-24       Impact factor: 4.241

Review 6.  Bone mineral density is negatively correlated with ulcerative colitis: a systematic review and meta-analysis.

Authors:  Tianyu Zhou; Jiaqi Pan; Bin Lai; Li Cen; Wenxi Jiang; Chaohui Yu; Zhe Shen
Journal:  Clin Transl Med       Date:  2020-02-18

7.  DSS-induced colitis produces inflammation-induced bone loss while irisin treatment mitigates the inflammatory state in both gut and bone.

Authors:  Corinne E Metzger; S Anand Narayanan; Jon P Elizondo; Anne Michal Carter; David C Zawieja; Harry A Hogan; Susan A Bloomfield
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

8.  Updates on bone health in children with gastrointestinal diseases.

Authors:  Hye Ran Yang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2020-03-31

Review 9.  Perspective on skeletal health in inflammatory bowel disease.

Authors:  A A van Bodegraven; N Bravenboer
Journal:  Osteoporos Int       Date:  2019-12-10       Impact factor: 4.507

10.  Health Maintenance Consensus for Adults With Inflammatory Bowel Disease.

Authors:  Gaurav Syal; Mariastella Serrano; Animesh Jain; Benjamin L Cohen; Florian Rieder; Christian Stone; Bincy Abraham; David Hudesman; Lisa Malter; Robert McCabe; Stefan Holubar; Anita Afzali; Adam S Cheifetz; Jill K J Gaidos; Alan C Moss
Journal:  Inflamm Bowel Dis       Date:  2021-10-18       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.